These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 1556796)
1. High 10-year survival rate in patients with early, untreated prostatic cancer. Johansson JE; Adami HO; Andersson SO; Bergström R; Holmberg L; Krusemo UB JAMA; 1992 Apr 22-29; 267(16):2191-6. PubMed ID: 1556796 [TBL] [Abstract][Full Text] [Related]
2. Expectant management of early stage prostatic cancer: Swedish experience. Johansson JE J Urol; 1994 Nov; 152(5 Pt 2):1753-6. PubMed ID: 7933233 [TBL] [Abstract][Full Text] [Related]
3. Natural history of early, localized prostate cancer. Johansson JE; Andrén O; Andersson SO; Dickman PW; Holmberg L; Magnuson A; Adami HO JAMA; 2004 Jun; 291(22):2713-9. PubMed ID: 15187052 [TBL] [Abstract][Full Text] [Related]
4. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. Johansson JE; Holmberg L; Johansson S; Bergström R; Adami HO JAMA; 1997 Feb; 277(6):467-71. PubMed ID: 9020270 [TBL] [Abstract][Full Text] [Related]
5. Natural history of early, localized prostate cancer: a final report from three decades of follow-up. Popiolek M; Rider JR; Andrén O; Andersson SO; Holmberg L; Adami HO; Johansson JE Eur Urol; 2013 Mar; 63(3):428-35. PubMed ID: 23084329 [TBL] [Abstract][Full Text] [Related]
6. [Natural disease course in untreated early prostatic carcinoma--the Orebro Study]. Johansson JE Praxis (Bern 1994); 2001 Sep; 90(36):1507-14. PubMed ID: 11593906 [TBL] [Abstract][Full Text] [Related]
7. [The natural course of untreated, localized primary prostate carcinoma]. Johansson JE Urologe A; 1996 Nov; 35(6):446-8. PubMed ID: 9064880 [TBL] [Abstract][Full Text] [Related]
8. Natural history of localised prostatic cancer. A population-based study in 223 untreated patients. Johansson JE; Adami HO; Andersson SO; Bergström R; Krusemo UB; Kraaz W Lancet; 1989 Apr; 1(8642):799-803. PubMed ID: 2564901 [TBL] [Abstract][Full Text] [Related]
9. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. Freedland SJ; Humphreys EB; Mangold LA; Eisenberger M; Dorey FJ; Walsh PC; Partin AW JAMA; 2005 Jul; 294(4):433-9. PubMed ID: 16046649 [TBL] [Abstract][Full Text] [Related]
10. Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison. Ghavamian R; Bergstralh EJ; Blute ML; Slezak J; Zincke H J Urol; 1999 Apr; 161(4):1223-7; discussion 1227-8. PubMed ID: 10081874 [TBL] [Abstract][Full Text] [Related]
11. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment. Aus G Scand J Urol Nephrol Suppl; 1994; 167():1-41. PubMed ID: 7542397 [TBL] [Abstract][Full Text] [Related]
12. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer. Zincke H; Lau W; Bergstralh E; Blute ML J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737 [TBL] [Abstract][Full Text] [Related]
13. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients. Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488 [TBL] [Abstract][Full Text] [Related]
14. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study. Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833 [TBL] [Abstract][Full Text] [Related]
15. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy. Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934 [TBL] [Abstract][Full Text] [Related]
16. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Shipley WU; Verhey LJ; Munzenrider JE; Suit HD; Urie MM; McManus PL; Young RH; Shipley JW; Zietman AL; Biggs PJ Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):3-12. PubMed ID: 7721636 [TBL] [Abstract][Full Text] [Related]
17. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study. Kibel AS; Rosenbaum E; Kattan MW; Picus J; Dreicer R; Klein EA; Chatta GS; Nelson JB; DiPaola RS; Roth BJ; Cookson MS; Wilding G; Jarrard DF; Beer TM; Ryan CW; Petrylak DP; Benson MC; Partin AW; Garrett-Mayer E; Eisenberger MA J Urol; 2007 May; 177(5):1777-81. PubMed ID: 17437819 [TBL] [Abstract][Full Text] [Related]
19. Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden. Aus G; Robinson D; Rosell J; Sandblom G; Varenhorst E; Cancer; 2005 Mar; 103(5):943-51. PubMed ID: 15651057 [TBL] [Abstract][Full Text] [Related]
20. Radical prostatectomy versus watchful waiting in early prostate cancer. Bill-Axelson A; Holmberg L; Ruutu M; Häggman M; Andersson SO; Bratell S; Spångberg A; Busch C; Nordling S; Garmo H; Palmgren J; Adami HO; Norlén BJ; Johansson JE; N Engl J Med; 2005 May; 352(19):1977-84. PubMed ID: 15888698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]